King Chulalongkorn Memorial Hospital / โรงพยาบาลจุฬาลงกรณ์
Hospital
Location:
Bangkok,
Thailand (TH)
ISNI: 0000000097588584
ROR: https://ror.org/05jd2pj53
Show on Map:
A Day 14 Endpoint for Acute GVHD Clinical Trials (2024)
Spyrou N, Akahoshi Y, Kowalyk S, Morales G, Beheshti R, Aguayo-Hiraldo P, Al Malki MM, et al.
Journal article
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease (2023)
Al Malki MM, London K, Baez J, Akahoshi Y, Hogan WJ, Etra A, Choe H, et al.
Journal article
The utility of biomarkers in acute GVHD prognostication (2023)
Spyrou N, Akahoshi Y, Ayuk F, Holler E, Choe H, Etra A, Hogan WJ, et al.
Journal article
Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD (2023)
Akahoshi Y, Spyrou N, Hogan WJ, Ayuk F, DeFilipp Z, Weber D, Choe HK, et al.
Journal article
The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease (2019)
Srinagesh H, Ozbek U, Kapoor U, Ayuk FA, Aziz MD, Ben-David K, Choe HK, et al.
Conference contribution
Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial (2017)
San-Miguel JF, Hungria VTM, Yoon SS, Beksac M, Dimopoulos MA, Elghandour A, Jedrzejczak WW, et al.
Journal article